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Fumonisins (FBs) are a family of mycotoxins
produced by Fusarium verticillioides (formerly
F. moniliforme; teleomorph Gibberella
fujikuroi) and related species that infect maize
and cause ear mold and stalk rot in field-
grown maize worldwide, especially in warmer
climates where maize is grown (1). F. verticil-
lioides is a major causal agent of symptomless
infection of maize, in which FBs can also be
present although usually at low levels (2). FBs
disrupt sphingolipid biosynthetic pathways in
both animal and plant cells, with potentially
profound consequences on cellular metabo-
lism (3). FBs are acutely toxic to certain live-
stock, especially horses and swine, and have
carcinogenic properties in rats (see other chap-
ters in this volume). FBs can be detected in a
variety of processed and unprocessed maize
grain products (4). Thus, they are a concern
for both animal and human consumers of
maize grain, especially in developing countries
(5) and in population segments where maize is
a major part of the diet.
The incidence and severity of Fusarium ear
mold and FB in maize varies widely with
growing season, location, and genotype (4). F.
verticillioides is often associated with symptom-
less infection of maize even where the extreme
environments associated with ear mold are less
prevalent (6). Typically, the Southeastern
United States fosters conditions that allow
heavy colonization by Fusarium: heat, high
humidity, and often a delay in harvest.
However, significant FB contamination can
occur even in the Central United States maize
belt in certain years (7). Other countries with
signiﬁcant maize acreage have also reported FB
levels that are cause for concern (8).
As natural products of a nearly ubiquitous
endophytic contaminant of maize, fumonisins
will be difﬁcult, if not impossible, to eliminate
from the food/feed chain, but steps can be
taken to minimize preharvest contamination
of maize. Environmental factors play a major,
although largely uncharacterized, role in inci-
dence of FB contamination of maize (9), but
host genetics undoubtedly plays a role as well.
Genetic modiﬁcation of maize (either through
plant breeding or transgene mediated) repre-
sents one potential way to reduce exposure to
this important mycotoxin in food and feed,
through increased resistance to fungal infec-
tion and/or toxin production in maize tissues.
This article describes current and proposed
genetic and molecular approaches that can
potentially lead to reduced exposure to FBs
from maize.
Breeding for Increased
Fusarium Ear Mold Resistance
Resistance to visible symptoms of Fusarium
ear mold can be selected for in environments
such as those mentioned above, where disease
pressure is severe enough to provide consis-
tent infection and visible mold (10).
However, symptomless infections may not be
taken into account with traditional screening
methods, and toxin-based screening methods
are also warranted. Fortunately, immunology-
based screening kits for FBs are available from
a number of manufacturers. Additional work
is needed to better deﬁne environmental con-
ditions that result in high levels of ear mold
and/or high levels of FB accumulation (9).
Genotype by environment interactions are
likely to be very important (11), and an anec-
dotal observation has been that high-yielding
northern lines, grown outside their area of
adaptation in the South, will often fare worse
than adapted lines under severe ear mold
pressure (12). Risk management, based on
well-characterized germplasm and better envi-
ronmental predictors, could certainly help
grain producers make the best choices for dis-
ease/mycotoxin management. Other tools,
including quantitative screening assays and
biomarkers for resistance, could potentially be
exploited as well (13). Exotic germplasm can
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be used as a source for increased ear mold
resistance (14), but difﬁculty is often encoun-
tered in introgressing this resistance into elite
material used for commercially viable hybrids.
Overall, with these tools and information
now available, prospects for improving the
level of Fusarium and FB resistance in hybrid
maize are good. However, the rate at which
advances can be made and the ultimate resis-
tance achieved may not match the require-
ments for FB-free maize. An additional
problem is that complex traits like ear mold
resistance may be difﬁcult to dissociate from
undesirable agronomic traits. 
The seed industry has been revolution-
ized by the advent of genetic transformation,
the process of inserting novel genes into the
crop’s genetic material, which results  in
enhancement of speciﬁc traits, often beyond
the natural genetic variation within the crop.
Transgene-derived insect resistance in maize
and herbicide resistance in soybeans consti-
tuted a major part of the respective markets
in the United States in 1999 (15). Most
transgenic crops on the market today have
traits whose beneﬁts are seen most clearly by
the grain producer, who enjoys a more stable
yield with fewer chemical inputs. Although
these beneﬁts are not always readily apparent
to the consumer, a newer generation of
transgenic crops is being developed with
improved nutritional properties (16) and
other qualities that will more directly affect
the consumer. Given the difficulty in con-
ventional breeding, the reduction in myco-
toxin contamination, specifically FB
contamination in maize, represents an area
where transgene technology could bring ben-
efits directly to the consumer. What are the
opportunities, and how are they likely to be
used in reducing the risk of FB contamina-
tion in food and feed?
Molecular Marker-Based
Breeding
Quantitative trait loci (QTL) are defined as
chromosomal regions that can be identiﬁed by
their statistical association with a measurable
trait in a segregating population. They repre-
sent the cumulative contribution of one or
more genes whose individual contribution to
resistance may be too small to detect. Traits
such as ear mold resistance that rely on more
than a few genes for optimal expression can be
mapped as QTL using large segregating popu-
lations (17). Molecular markers linked to
these QTL could potentially provide an aid to
conventional breeding in introgressing com-
plex traits during inbred development.
Advances in marker technology have made
this feasible (although still expensive) today in
ﬁeld crops (18). However, complex traits may
depend upon the action of other genes that
may vary by genetic background, so it is
questionable whether marker-assisted selection
will result in a universal set of genes with
equal potency in all hybrids.
Several public researchers have made sig-
nificant progress in mapping natural resis-
tance to Aspergillus ear mold, and we may
now be in a position to test the usefulness of
marker-assisted selection for ear mold resis-
tance in maize hybrid development. There are
currently no similar publicly funded projects
to map Fusarium ear mold loci, although
resistant germplasm has been identiﬁed (19).
Work is underway to identify and map loci
associated with Gibberella ear mold resistance
(20), although it is likely that resistance fac-
tors involved in resistance to Gibberella are
different from those responsible for Fusarium
ear mold resistance. 
Genes for Ear Mold Resistance
in Maize
What about the genes themselves? Map-based
cloning of genes has become feasible in sev-
eral plant species, including soybean (21).
QTL mapping, together with the candidate
gene approach to linking expressed cDNAs to
resistance-related loci (22), could conceivably
allow the identification of genes that con-
tribute to quantitative resistance to Fusarium
ear mold. The large size of the maize genome
makes this exceedingly difficult at present,
but technologic advances including large-scale
genomic sequencing and physical mapping
may allow breakthroughs.
Transgenic Resistance to
Ear-Feeding Insects
Genes that reduce insect feeding would be
predicted to result in lower mycotoxin levels
in maize under conditions where insects are a
major factor in dispersal of the fungus and
subsequent infection through insect-wounded
kernels. Genes coding for insecticidal proteins
from Bacillus thuringiensis (Bt) (23) have been
expressed in transgenic maize hybrids to
counteract the effects European corn borer
feeding on leaf and stalk tissues. Maize
hybrids containing genes coding for the δ-
endotoxins Cry1Ab and Cry1Ac have been
widely planted in the United States since
1997 (15). In several commercialized ver-
sions, Bt protein is expressed in kernels as
well as in green tissues, and thus could confer
protection against corn borer-mediated ear
damage. Recent data from multiyear experi-
ments involving a range of Bt hybrids grown
in the Midwest (24) indicate that presence of
the Bt gene can result in reduced FB levels
relative to the same hybrid without the Bt
gene. The effect was seen under conditions of
both natural and artificial infestation with
European corn borer, but was absent or less
pronounced in some cases. Visible symptoms
were also typically reduced. These data
suggest that Bt maize can be part of a strategy
for reducing ear molds and mycotoxins. If
additional Bacillus genes are eventually
deployed to control a broader range of insects
that feed in ears, the degree of effectiveness
may be improved even further. However,
there is a caveat, in that insects may not be a
limiting factor in ear mold severity in all envi-
ronments. In addition, the use of Bt genes
expressed in kernel tissues has been restricted
in certain areas of the Southern United States
where corn earworms can also feed on cotton
(25), and this area includes regions where
Fusarium ear mold is often a problem. In
summary, Fusarium has multiple routes of
entry to the ear (26), and resistance to ear
mold per se will continue to be the most
important part of a strategy to reduce myco-
toxins in maize grain.
Transgenic Strategies to
Reduce Fusarium Ear Mold
Transgene-enhanced disease resistance has
not yet achieved the same level of success as
insect resistance in crop plants. Despite the
early success of genes for transgenic virus
resistance (27), achieving a convincing level
of resistance to fungi has proven more diffi-
cult, although success has been reported in
model system species (28) and in some crop
species (29). Even with moderate success in
greenhouse or growth chamber, the ability of
transgene efficacy to hold up under diverse
environments and genotypes in the field is
even more challenging. Perhaps as a reﬂection
of this difficulty, no transgenic crops with
enhanced resistance to fungi are currently on
the market in 2001. 
Large amounts of both public and private
research dollars are being spent attempting to
generate transgenic plants with increased
resistance to diseases, including Fusarium ear
mold in maize. Several companies have maize
ﬁeld trials in the category Fusarium resistant
or ear mold resistant in the U.S. Department
of Agriculture Animal and Plant Health
Inspection Service Field Test Release
Database for 2000 (30). However, the process
of delivering transgenes to market in a crop
such as maize is complex and potentially
lengthy (31). Ear mold resistance in maize
presents a formidable challenge at this early
stage in trait-directed transgene technology,
in part because of our inadequate knowledge
of the basic biology of the interaction: where,
when and how Fusarium infects the kernel,
how ear mold symptoms arise, and when and
where mycotoxins such as FB are produced in
the ear. Still, opportunities exist to evaluate
genes and strategies that have shown promise
in other host–pathogen systems. The follow-
ing sections provide additional details of these
strategies as they apply to ear mold resistance
in maize.
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Antifungal Proteins
Mature maize kernels contain several classes of
proteins with known antifungal activity
(32–37), and these may contribute to the gen-
eral or specific resistance to infection by
pathogens. However, establishing a role for
individual proteins in disease resistance is
often difﬁcult. This is probably because plants
use multiple or even redundant mechanisms
that together result in a resistance response
but individually may not play an obvious role.
Nevertheless, genetic engineering can poten-
tially be used to augment a given level of resis-
tance by introducing novel antifungal proteins
or protein combinations, as has been reported
for several leaf pathogens in dicots (38). Few
successful examples of transgenic disease resis-
tance have been published for monocots (39).
Antifungal proteins are generally much less
potent against their targets than is Bt on a
weight basis, and extremely high-level expres-
sion may be needed to affect fungal growth in
tissue. Gene silencing may be brought on by
high level expression of homologous gene
sequences (40), so genes not of maize origin
may be preferable. An additional considera-
tion is that high-level expression of a seed pro-
tein could change kernel morphology in ways
that could result in a change in susceptibility
to ear mold. In a nontransgenic example,
opaque-2 endosperm was reported to result in
more severe Fusarium ear mold in already sus-
ceptible backgrounds (41). An alternative
strategy would be to deploy an antifungal pro-
tein in a nonseed tissue that is critical for
infection (e.g., silk, husk), although there is
little data to suggest that silks are a limiting
factor for infection, unlike the situation with
F. graminearum (20). 
The foregoing discussion illuminates
some of the technical challenges that need to
be overcome to successfully engineer resis-
tance via one or several transgenes with direct
antifungal activity. Thus far no commercial
level of resistance has been reported using
antifungal proteins.
Engineered Secondary Metabolites
Plants produce chemical defenses, either con-
stitutively or in response to infection (42).
Several secondary metabolites in the maize
kernel have been implicated in resistance to
Aspergillus and Gibberella ear molds, including
hydroxamic acids (43), phenolics (44), and
volatiles (45). Although some enzymes
involved in secondary metabolite synthesis in
maize have been cloned (46) and could thus
be potentially manipulated by overexpression
of pathway-limiting enzymes, such pathways
are relatively uncharacterized in maize.
Opportunities also exist to introduce novel
metabolites into a crop species if a common
precursor is present. The ideal metabolite is
one that is already found in a food crop and
can be readily ascertained to be safe. As an
example, antifungal stilbenes, products of a
single polyketide synthase, can be synthesized
in plants that do not normally make them
(47). One potential pitfall in this approach is
the possibility that diversion of metabolic
pathways into antifungals may compromise
another biosynthetic route that shares interme-
diates with the pathway of interest. Although
challenging, the area of metabolic engineering
has long-term promise for engineering novel
traits including disease resistance.
Transgene-Enhanced Defense Pathways
Host plant–pathogen interactions are complex
and likely involve multiple proteins and
metabolites with both sides taking part in a
microscopic war for biomass and nutrients.
Although our level of knowledge about molec-
ular interactions between host and pathogens
is increasing rapidly (48), we still do not have
enough information about the genes and path-
ways to intervene successfully in most diseases.
One recent focus has been the signal response
pathways that transmit information about a
stress or pathogen and generate a host response
(often involving novel gene expression) to
combat the stress or infection (49). The signal-
ing pathways, similar to mammalian signal cas-
cades, control a variety of cellular responses,
using multiple steps or cascades involving pro-
tein–protein interactions that allow a few genes
to control the action of many. This host
response may or may not culminate in hyper-
sensitive cell death in surrounding tissue and
may also result in activation of defense path-
ways in adjacent tissues or even systemically in
the plant (50). If the master signals that con-
trol defense gene expression can be identiﬁed,
they could potentially be engineered to provide
a more rapid response, a constitutive response,
or a chemically induced defense response (51).
Such a series of master genes potentially con-
trolling cold tolerance in Arabidopsis has been
identiﬁed (52). Overexpression of one of these
factors, CBF1, is reported to result in
enhanced cold tolerance in recipient transgen-
ics, presumably by upregulating the entire suite
of genes necessary for cold tolerance (53).
Through genetic and molecular techniques, a
number of genes that control disease resistance
pathways have been identified in the model
plant species Arabidopsis, and overexpression of
these genes can result in an enhanced disease
resistance phenotype (54,55). It would be
somewhat surprising if this type of constitutive
up-regulation did not come at some cost in
energy availability or flexibility to combat
other pathogens or pests, but no one has yet
addressed these questions with meaningful
experiments. It is encouraging that several
transgenic routes to constitutive resistance have
already been identified, and with time it
should be possible to sort out which (if any)
work best in actual field conditions. Many
research groups are using powerful molecular
techniques for detecting changes in expression
of large numbers of genes simultaneously, with
the aim of identifying defense pathways and
controlling genes in plants such as maize (56). 
Most of the experiments cited above
involved dicot leaf pathogens. What about
maize, and particularly, what about kernel tis-
sues? Induction of defense pathways has been
observed in maize (57), although it remains
to be seen whether these defense pathways
will provide effective control against maize
pathogens. In addition, there is very little data
on the effectiveness of induced cellular resis-
tance pathways in developing seed tissues in
any species, although a few studies of germi-
nating seeds indicate defense gene expression
can be enhanced by elicitor application fol-
lowing germination (58).
Gene-for-Gene Resistance to Fusarium
In some instances, plant resistance to a
pathogen can be characterized genetically in
terms of a dominant resistance gene (R gene)
in the plant and a corresponding avirulence
gene (avr gene) that must be present in the
pathogen in order for a resistance response to
occur. Several R genes and, in some cases,
corresponding avr genes have been cloned
and characterized (59). R genes fall into sev-
eral related classes of proteins, often contain-
ing both potential protein-binding domains
(leucine-rich repeats) and response regulator
domains, whereas avr genes vary widely in
size and structure. Attempts are underway to
understand how interaction of these host and
pathogen gene products could directly or
indirectly lead to a signal cascade (60). In
maize, Rp1-D conferring resistance to the
common rust Puccinia graminis (an obligate
fungal parasite) has been cloned (61).
There is no evidence of a gene-for-gene
relationship in Fusarium ear mold of maize.
As discussed earlier, known sources of resis-
tance are likely to be polygenic. Several other
Fusarium species have gene-for-gene interac-
tions with their plant hosts. For example, in
tomato an R gene conferring resistance to a
race of F. oxysporum has been mapped and a
candidate gene cloned (62). It is possible that
through protein engineering/directed evolu-
tion (63), novel R gene speciﬁcities could be
developed that would allow maize to recog-
nize F. verticillioides in a gene-speciﬁc manner
via factors secreted by the fungus during
infection of maize. However, a hallmark of
gene-for-gene interactions is the often rapid
evolution of novel races of the pathogen that
overcome resistance by loss of avr gene func-
tion (64). The diversity of toxigenic Fusarium
species capable of infecting maize would cre-
ate a significant challenge for an engineered
recognition system.
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Transgenic Strategies Aimed
at Reducing Fumonisins 
Although reducing fungal infection through
host resistance remains the most desirable
method to eliminate mycotoxins, strategies
directed against a mycotoxin per se (either
suppressing its synthesis or degrading it to
nontoxic metabolites) represent an alternative
or complementary means to address myco-
toxin contamination. This approach may be
desirable in two situations: a) in crop molds
in which the mycotoxin itself is a participant
in disease or symptom development, so
reducing toxin levels would also be expected
to reduce disease; and b) in crop genotypes or
environments where there is minimal overt
mold damage to grain overall, but a fungal
toxin or family of toxins is still present and
poses a potential threat to consumers.
Deoxynivalenol, a mycotoxin produced by
F. graminearum, has been proposed to play a
phytotoxic role in both wheat scab and maize
ear mold diseases caused by this fungus
(65,66), and it is possible to envision resistance
strategies that involve reducing the impact of
this toxin on host tissue. FBs, although they
are somewhat phytotoxic to many plant species
including maize (67), are apparently not
strongly associated with pathogenicity or
symptom severity in F. verticillioides diseases of
maize (68). Whether FBs are not involved at
all in the etiology of Fusarium diseases of
maize, or whether they play a role along with
other toxic factors is not known. In any case,
there is currently no compelling evidence to
suggest that FB detoxification in planta will
alter the course of Fusarium infection. 
However, strategies targeted at FB reduc-
tion may be worthwhile nonetheless.
Although high FB levels in grain are usually
correlated with symptomatic (i.e., damaged
or visibly moldy) kernels, FBs can also be
detected in asymptomatic kernels, coincident
with the asymptomatic presence of Fusarium
(2). FB contamination can occur in grain that
would not be ﬂagged as moldy, and strategies
to reduce or eliminate FB in this grain should
be given consideration. 
Modifying Mycotoxin Catabolic
Pathways
Most mycotoxins are produced under speciﬁc
cultural conditions, and there is evidence that
plant host-produced signals can play either a
positive or a negative role in toxin accumula-
tion (69,70). Developmental changes in ker-
nel composition can also inﬂuence mycotoxin
production, as was reported recently in a
study of FB production on sterilized maize
kernels at different stages of development
(71). One approach, therefore, would be to
engineer a plant to produce a soluble signal to
turn off the mycotoxin pathway in the fungus
or, alternatively, fail to produce an essential
signal that would normally turn on toxin pro-
duction. Natural products that have a suppres-
sive effect on mycotoxin production have been
reported (43). Manipulation of lipid hydroper-
oxides represents a possible route towards the
reduction of aﬂatoxin in grain (69). A recent
report suggests that FB biosynthesis by F. ver-
ticillioides is subject to nitrogen repression
(72), although this pathway may not be easy to
manipulate without other effects on grain.
If mycotoxin biosynthetic pathway genes
can be identiﬁed, molecular methods involving
promoter/marker gene fusions can be used to
simplify screens for modulators of the pathway
(73). To date, these tools have not been used in
high throughput screens, so their usefulness has
not been put to the test. The ﬁrst FB biosyn-
thetic pathway gene has recently been cloned
(74), opening up the possibility of metabolite
screens for Fusarium as well. It is difﬁcult to
predict how difﬁcult this strategy will be to put
into practice for FB until the key factors that
turn production on or off are identiﬁed. 
Detoxiﬁcation of Mycotoxins in Planta
Another transgene-based method for reducing
mycotoxin accumulation involves the deploy-
ment of catabolic enzymes to detoxify the
mycotoxin in situ before it can accumulate in
the plant. This topic has been the subject of a
recent literature review (75). This strategy,
although an untested concept insofar as myco-
toxins are concerned, is one that plants may
deploy naturally in their defense against certain
fungi that produce toxins as disease agents.
For example, most maize genotypes produce
an NADH reductase enzyme that inactivates
a fungal toxin produced by race 1 of
Cochliobolus carbonum (76). In the absence of
Hm1, the gene coding for this reductase (77),
seedlings are highly susceptible to this fungus.
There are several reports in the literature in
which microbial genes coding for detoxiﬁca-
tion enzymes have been expressed successfully
in plants, with a resulting reduction in disease.
An early example is that of tabtoxin and wild-
ﬁre resistance developed in tobacco using an
acetyltransferase enzyme from the pathogen
itself, Pseudomonas syringi pv. tabaci (78). Lu et
al. (79) have presented data indicating that
transgenic expression of wheat oxalate oxidase,
which detoxifies oxalic acid produced by
Sclerotinia sclerotiorum, can reduce white mold
disease caused by Sclerotinia in sunflower;
Zhang et al. (80) reported the successful engi-
neering of resistance to a pathogenic bacterium
in sugarcane using a detoxifying gene, AlbD,
obtained from a biocontrol organism. These
reports demonstrate that in some cases not
only the toxin but the disease can be controlled
by a degradative enzyme. 
The success of a detoxiﬁcation approach for
mycotoxins will depend in part on the extent to
which the plant-produced enzyme reaches its
target substrate and the effectiveness or stability
of the detoxiﬁcation step. For FBs in maize, lit-
tle is known about their cellular location, so it
is difﬁcult to predict how successful a detoxiﬁ-
cation approach could be. However, FBs are
water soluble, and it seems likely that most of
the toxin would be available to soluble enzymes
produced in host tissues. In addition, key func-
tional groups (tricarballylate esters and a pri-
mary amine) that affect toxicity (81) make FB
an attractive molecule for detoxification.
However, much data suggest that merely
removing tricarballylates does not render the
molecule nontoxic (82), so multistep modiﬁca-
tion may be necessary. Generally, FBs appear
resistant to the activity of known esterases and
amine-modifying enzymes (83,84), so novel
enzymes and genes must be sought.
The identification of several microbial
species (both fungal and bacterial) that
metabolize the C-20 backbone portion of FBs
to CO2 in liquid culture has opened up the
possibility of engineering maize that detoxi-
fies FBs (85–87). Two fungal species
(Exophiala spinifera and Rhinocladiella atro-
virens), belonging to the dematiaceous
hyphomycetes known as black yeasts (88),
can grow on FB1 as a sole carbon source and
produce enzymes in culture that metabolize
FBs (89). One of these, E. spinifera, has been
used as a source for genes in a strategy aimed
at detoxification of FBs in transgenic maize.
The initial step in FB metabolism by E.
spinifera consists of deesterification of FB’s
tricarballylic acid esters by a FB-speciﬁc, solu-
ble esterase, ESP-1 (85). Ester hydrolysis is
followed by oxidative deamination of the
resulting amine alcohol backbone by an
amine oxidase enzyme (84), resulting in a 2-
oxo polyalcohol (2-OP1) that undergoes
internal cyclization to form a hemiketal (90)
(Figure 1). Together, these two catabolic
steps are likely to detoxify FB, although toxi-
cologic data to verify this are not yet avail-
able. We hypothesize that the esterase, amine
oxidase, and other downstream enzymes
together constitute a novel catabolic pathway
that provides a unique carbon-source niche
for microbes that express them. We have
cloned genes corresponding to the two FB-
specific enzymes that carry out the catalytic
processes described above (deesterification
and oxidative deamination) (86,87,91).
Experiments are under way to evaluate the
effect of these genes, when expressed in trans-
genic maize, on FB levels in the grain. 
Unlike transgene-mediated herbicide resis-
tance in which the successful phenotype is
self-selecting (i.e., plant survival and growth),
engineering the breakdown of a xenobiotic
toxin like FB will require extensive and com-
plex analysis to determine its efﬁcacy. It will
be important to establish a number of
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benchmarks for the success of this approach to
FB reduction, all of which will determine the
extent of mycotoxin breakdown possible in a
transgene. These include: a) enzyme localiza-
tion in the seed in relation to mycotoxin sub-
strate accessibility; b) kinetic parameters of the
enzyme(s) in the context of its localization in
the plant (substrate Km, pH optimum, sub-
strate range, potential inhibitors); and c) sta-
bility and activity of the enzyme during pre-
and postharvest conditions conducive to fun-
gal growth. Equally important will be experi-
ments that verify the identity of mycotoxin
breakdown products that accumulate in the
transgenic grain under ear mold conditions,
the toxicity of these products in a variety of
test systems, in comparison to FBs, and the
nutritional properties of the transgenic grain
under various mold conditions. In addition,
regulatory processes set in place by U.S. agen-
cies that oversee transgenic food safety con-
cerns under the Food, Drug and Cosmetics
Act (92) will need to be met.
If all of these benchmarks are achieved,
genes for reducing FB levels in maize could be
incorporated into existing germplasm that
already has adequate levels of Fusarium ear
mold resistance overall but still carries a risk of
FB contamination depending on the growing
environment. In principle, other detoxiﬁcation
enzymes could be stacked together to provide
broader protection from risk of adverse levels
of a range of mycotoxins.
Summary and Conclusions
The potential for improvement of maize
through molecular genetics-based enhance-
ment of elite germplasm is now being realized
in areas of insect resistance and herbicide tol-
erance. Insect resistance genes can have an
impact on ear mold and mycotoxin levels, but
will not eliminate the problem. First-genera-
tion genetic enhancement of maize will soon
be augmented by additional improvements in
both input and output traits, perhaps includ-
ing increased resistance to fungal diseases
such as Fusarium. Transgene-mediated fungal
resistance has not yet reached its commercial
potential in field crops, but advances in
understanding of fundamental mechanisms of
host resistance and fungal pathogenicity are
setting the stage for this becoming reality.
New strategies such as detoxiﬁcation are also
worth pursuing, as we need to test the limits
of transgene technology to help solve these
difﬁcult food and feed safety problems.
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